RAC 1.27% $1.55 race oncology ltd

Ann: Race Strategic Update March 2021, page-382

  1. 2,679 Posts.
    lightbulb Created with Sketch. 10298
    The problem with taking the Pandion approach is unlike Pandion is we don’t have a register dominated by biotech VC funds who will hold out for a better deal. For better or worse RAC's registry is made up of Australian retail investors who have a history of selling out early for a minor premium.

    I want to see us get on with out clinical programs and once we have FTO data approach big pharma.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55
Change
-0.020(1.27%)
Mkt cap ! $264.0M
Open High Low Value Volume
$1.59 $1.62 $1.51 $218.3K 138.7K

Buyers (Bids)

No. Vol. Price($)
1 95 $1.53
 

Sellers (Offers)

Price($) Vol. No.
$1.55 157 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.